A knowledge-based, highly innovative industry has developed over the past 20 years. Its international importance is expressed through a global network of cooperation partners.
In the extremely protracted, high-risk, and expensive product development cycles for new medications, Bavaria has been able to establish itself as a location for the early identification and validation of suitable drug candidates.
In addition to a number of successful SMEs with specific products or technology offerings, one of Europe's largest research and production facilities for biopharmaceuticals – Roche in Penzberg with currently more than 6,000 employees – is located south of Munich. The complete value chain, from research to pre-clinical and clinical development to production, is a particular characteristic of this industry that is firmly rooted in Bavaria.
Another key focal point of the network is the international image and presentation of the latest technologies and products of Bavarian companies along with the excellent scientific basis of research institutions in Bavaria.
